# Giovanni Melillo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giovanni-melillo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,975 |
| Field | Cancer, Hypoxia, and Metabolism |
| h-index | 51 |
| i10-index | 93 |
| Last Known Institution | AstraZeneca (Brazil) |
| OpenAlex ID | https://openalex.org/A5000029047 |
| Works | 167 |

## Researcher papers

- [Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer](https://scholariq.org/papers/durvalumab-after-chemoradiotherapy-in-stage-iii-non-small-cell-lung-cancer/)
- [Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC](https://scholariq.org/papers/overall-survival-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/)

## Researcher topics

- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

## Researcher university

- [AstraZeneca (Brazil)](https://scholariq.org/institutions/astrazeneca-brazil/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.